Last reviewed · How we verify

Hydrocodone-Acetaminophen

Henry Ford Health System · FDA-approved active Small molecule

Hydrocodone is an opioid agonist that binds to mu opioid receptors in the central nervous system to reduce pain perception, while acetaminophen inhibits prostaglandin synthesis to provide additional analgesic and antipyretic effects.

Hydrocodone is an opioid agonist that binds to mu opioid receptors in the central nervous system to reduce pain perception, while acetaminophen inhibits prostaglandin synthesis to provide additional analgesic and antipyretic effects. Used for Moderate to moderately severe pain.

At a glance

Generic nameHydrocodone-Acetaminophen
Also known asNorco, Opioid, Vicodin, Lortab
SponsorHenry Ford Health System
Drug classOpioid analgesic combination
TargetMu opioid receptor (hydrocodone); COX inhibitor (acetaminophen)
ModalitySmall molecule
Therapeutic areaPain Management
PhaseFDA-approved

Mechanism of action

Hydrocodone acts as a mu opioid receptor agonist, modulating pain signals in the brain and spinal cord. Acetaminophen works through a separate mechanism, inhibiting cyclooxygenase enzymes and reducing prostaglandin production, which contributes to pain relief and fever reduction. The combination provides synergistic analgesia for moderate to moderately severe pain.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: